MENLO PARK, Calif. (AP) — MENLO PARK, Calif. (AP) — Corcept Therapeutics Inc. (CORT) on Wednesday reported third-quarter profit of $46.7 million.
The Menlo Park, California-based company said it had profit of 41 cents per share.
The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of 27 cents per share.
The drug developer posted revenue of $182.5 million in the period, which also beat Street forecasts. Four analysts surveyed by Zacks expected $172.1 million.
Corcept expects full-year revenue in the range of $675 million to $700 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CORT at https://www.zacks.com/ap/CORT
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。